Skip to content
Lower risk Medical device recall · FDA · Published April 16, 2026

EXENT Analyser Software Version 1.0.20: False M-protein Results Risk

The Binding Site Group recalls EXENT Analyser software version 1.0.20 due to potential false M-protein results. Affected units may show inaccurate test results, requiring immediate verification with a different method.

🇺🇸 FDA recall #Z-2362-2026Medical deviceThe Binding Site Group ›
Take action

Contact the company

Recalling firmThe Binding Site Group, Ltd.8 Calthorpe Road · Birmingham, United Kingdom
✎ GovInfoNow plain-language explainer

The Binding Site Group recalls EXENT Analyser software version 1.0.20 because it may produce false or missed M-protein results. This could lead to incorrect diagnoses or treatment decisions for blood disorders. Read more at govinfonow.com/recall/49460-exent-analyser-software-version-1-0-20-false-m-protein.

Source Summary by GovInfoNow · govinfonow.com/recall/49460-exent-analyser-software-version-1-0-20-false-m-protein · Updated August 17, 2026 · FDA enforcement record: FDA #Z-2362-2026

Cite this page

“EXENT Analyser Software Version 1.0.20: False M-protein Results Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/49460-exent-analyser-software-version-1-0-20-false-m-protein. Based on FDA recall #Z-2362-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2362-2026%22&limit=1).

The FDA announced on April 16, 2026, that The Binding Site Group, Ltd. is recalling the EXENT Analyser (Model IE800.A) due to quality control failures that may lead to false or missed detection of M-protein.

How to tell if you have it

  • Brand: EXENT Analyser
  • Model/Catalog Number: IE800.A
  • Software Version: 1.0.20
  • Lot Code: Model No; IE800A; EXENT Analyser; UDI; 05051700020886, Serial Number; 101150, Software version; v1.0.20

The hazard

The FDA stated that plates 2 and 3 were marked as passed despite quality control not being performed, posing potential clinical hazards including false positive detection or falsely elevated or decreased M-protein concentration.

Context

GovInfoNow's records show The Binding Site Group, Ltd. has 15 other recalls on record since August 23, 2017. Other recent recalls of similar products include Freelite Human Lambda Free Kit Recall (October 15, 2021), FREELITE Human Kappa Free Kit recall (May 20, 2021), and Optil: Freelite Mx Kappa Free Kit recall (November 18, 2020). Vivoo Protein Test Recall occurred on November 22, 2025, and Exploro Fertility Test Recall also occurred on November 22, 2025. TECHNO-PATH Multichem ID-B Serum Recall was reported on October 17, 2025.

How to tell if you have this one

Check for software version 1.0.20 on the EXENT Analyser. The model number is IE800.A and it was sold with lot code 05051700020886.

  • Brand
    The Binding Site Group
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Software Version

    Verify the software version on your EXENT Analyser; if it is 1.0.20, it is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Apr 16, 202612. FDA classified it Class II: Jun 9, 202623. Published in FDA’s Enforcement Report: Jun 17, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2362-2026 (April 16, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2362-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA